Cargando…
HIV drug resistance and antiretroviral therapy programs in Henan, China
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029157/ https://www.ncbi.nlm.nih.gov/pubmed/32099967 http://dx.doi.org/10.1016/j.eclinm.2020.100275 |
| _version_ | 1783499108486479872 |
|---|---|
| author | Liu, Zhi-Bin Li, Qiang Guo, Huijun |
| author_facet | Liu, Zhi-Bin Li, Qiang Guo, Huijun |
| author_sort | Liu, Zhi-Bin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7029157 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70291572020-02-25 HIV drug resistance and antiretroviral therapy programs in Henan, China Liu, Zhi-Bin Li, Qiang Guo, Huijun EClinicalMedicine Letter Elsevier 2020-02-17 /pmc/articles/PMC7029157/ /pubmed/32099967 http://dx.doi.org/10.1016/j.eclinm.2020.100275 Text en © 2020 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter Liu, Zhi-Bin Li, Qiang Guo, Huijun HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title | HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title_full | HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title_fullStr | HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title_full_unstemmed | HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title_short | HIV drug resistance and antiretroviral therapy programs in Henan, China |
| title_sort | hiv drug resistance and antiretroviral therapy programs in henan, china |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029157/ https://www.ncbi.nlm.nih.gov/pubmed/32099967 http://dx.doi.org/10.1016/j.eclinm.2020.100275 |
| work_keys_str_mv | AT liuzhibin hivdrugresistanceandantiretroviraltherapyprogramsinhenanchina AT liqiang hivdrugresistanceandantiretroviraltherapyprogramsinhenanchina AT guohuijun hivdrugresistanceandantiretroviraltherapyprogramsinhenanchina |